[68A3-68A3];[68A6-68A6];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
68A3;68A6
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3L)BSC674.
Pfdn201239/Df(3L)BSC457 mutants show ectopic neuroblasts in third instar larval brains and an increase in the number of cells in S-phase (assessed by EdU labelling).They also display defects in asymmetric protein segregation (both in metaphase and telophase) and mitotic spindle orientation in neuroblasts.
The presence of P+PBac{XP5.WH5}BSC457 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(3L)BSC457 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}CG6327f02990 and P{XP}d07141 insertion sites are 68A3;68A6.